Pancreatic cancer, or pancreatic ductal adenocarcinoma (PDAC), is often described in stark terms: one of the most lethal cancers known to medicine. With an estimated five-year survival rate hovering around a grim 10%, this aggressive disease frequently slips past early detection, leaving patients with limited treatment avenues once it’s discovered. For decades, the outlook has … Read more
In a startling development that could redefine cancer treatment, scientists have successfully engineered a common probiotic yeast to act as a miniature drug delivery system, shrinking hard-to-reach intestinal tumors in mice. This groundbreaking work, out of Washington University School of Medicine in St. Louis, offers a glimmer of hope for a less invasive, oral treatment … Read more
Researchers at Washington University School of Medicine in St. Louis have revealed two key transition points in the development of pancreatic cancer.
New research suggests specific gut bacteria could help identify pancreatic cancer, regardless of the stage of the disease.
Researchers from Spain may have found a way to detect pancreatic cancer earlier using patient stool samples.